Efficacy of antimanic treatments in mixed states. - Wikidata - awgldk - TriplyDB

Efficacy of antimanic treatments in mixed states.

Efficacy of antimanic treatments in mixed states.

http://www.wikidata.org/entity/Q38003197

about

Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care The diagnosis and treatment of bipolar disorder: decision-making in primary care.Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.Asenapine augmentation in bipolar disorders: a case series.Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder.The clinical management of bipolar disorder complexity using a stratified model.Clinical decision making in the treatment of mixed states.Treatment recommendations for DSM-5-defined mixed features.Treatment of mixed features in bipolar disorder.Treating mixed mania/hypomania: a review and synthesis of the evidence.Guidelines for the recognition and management of mixed depression.The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.Thoughts on suicidal thinking in bipolar disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

P2860

Q33975840-080F33CD-4D9A-437D-B135-D09B8BB68DC2 Q34331882-CE8477D4-4B93-4455-9310-9F03226D72AB Q34636572-4D7D17E5-1832-4E40-8E69-EF86FF032AC1 Q36868401-AEB940DD-59CB-49C0-B9E1-3A333DFDCFE8 Q38003196-580CCD3B-3E48-4176-A9FB-4A1814AAF66A Q38003199-88C43515-1B61-47D6-9AFA-9B03397E62B0 Q38211511-A221B343-D0B0-475D-B252-5AFF02138C31 Q38821179-E4279E99-CF99-4E38-A0B6-D43945C62E59 Q38952103-25D88B21-27A8-498B-8471-8DDFFD4EFC6F Q39048607-8A9537EE-3197-4F1B-84D1-61EB7E3679D8 Q46300154-AC36A2FC-C29D-4643-85B8-842F616F715E Q47980447-2E67C9E7-8958-4EDF-B7FA-0279FFF0B777 Q48182452-2C30F892-EE42-44E9-BC61-D899AAEF1EC6 Q52656684-BA6C215B-456C-4975-9023-9150845C0D39

P2860

Efficacy of antimanic treatments in mixed states.

http://www.wikidata.org/entity/Q38003197

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Efficacy of antimanic treatments in mixed states.

@en

type

label

Efficacy of antimanic treatments in mixed states.

@en

prefLabel

Efficacy of antimanic treatments in mixed states.

@en

P1433

Q38003197-4E628F56-7028-45F2-BFEA-4448C80D5ABA

P1476

Q38003197-1AADF366-2CDE-484D-BBDB-1DACCD2BFCC4

P2093

Q38003197-1BBC3663-0A69-46A0-9F36-C5F70A250BE6

Q38003197-898E1882-CC16-4F81-814F-10F35AE23E8D

P2860

Q38003197-0F0485EA-5659-47A1-9D31-ED75FAA520A1

Q38003197-197702FA-3A35-45F5-973D-62A213C64469

Q38003197-1D30E72D-7268-421F-811E-758CD669E1B0

Q38003197-210AC337-B56B-4862-AF56-936F97205EFF

Q38003197-2D6CA3E9-6AED-4970-8C4B-6861583065F0

Q38003197-32F0D2B5-FF5E-4B07-B503-26B7EC9AE61E

Q38003197-33A44440-3071-4275-8CDA-D13F6336F41F

Q38003197-4011C3E2-9CD8-4825-B2B9-C20F1183B5DF

Q38003197-413561D3-35E7-4925-AF2E-5AFDFE742396

Q38003197-44C6A46C-4A32-498F-8BC3-57E70C9AE784

P304

Q38003197-30DE8F1C-7EB1-4AAA-9B73-CFB3B4F39B08

P31

Q38003197-6E293A8D-0A4A-476F-9FCA-D68CF9DEE073

P356

Q38003197-9657549B-5451-4BD2-8CC6-1ADE831C9052

P478

Q38003197-2881FC53-4B5D-414A-9841-254AE89265F3

P577

Q38003197-8ABF7311-FE09-4F31-94F2-CED99D986E32

P698

Q38003197-1976D17A-D4C9-448B-9929-C5E9D0519056

P356

J.1399-5618.2012.00990.X

P1433

Bipolar Disorders

P1476

Efficacy of antimanic treatments in mixed states.

@en

P2093

Jinju Yoon

http://www.w3.org/2001/XMLSchema#string

Roger S McIntyre

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.

Exercise and bipolar disorder: a review of neurobiological mediators.

Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.

Bipolar disorder and metabolic syndrome: an international perspective.

Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda.

P304

22-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-5618.2012.00990.X

http://www.w3.org/2001/XMLSchema#string

P478

14 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22510034

http://www.w3.org/2001/XMLSchema#string